Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Marine Pharmaceuticals Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.
The marine pharmaceuticals market is forecasted to grow by USD 1.95 billion during 2023-2028, accelerating at a CAGR of 8.63% during the forecast period. The market is driven by rising consumer demand for natural products, the growing prevalence of chronic diseases, and the presence of rich marine biodiversity.
This study identifies the rise of antibiotics from marine microbes as another prime reason driving the marine pharmaceuticals market growth during the next few years. Also, research for anti-inflammatory compounds from marine sources and the emergence of digitalization and data analytics will lead to sizable demand in the market.
The report on the marine pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
The marine pharmaceuticals market is segmented as below:
By Product
- Oncology
- Cardiovascular
- Anti-infectives
- Others
By Type
- Health supplements
- Drugs
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the marine pharmaceuticals market covers the following areas:
- Marine pharmaceuticals market sizing
- Marine pharmaceuticals market forecast
- Marine pharmaceuticals market industry analysis
The report includes key vendor analysis, providing detailed analysis of several leading marine pharmaceuticals market vendors that includes:
- Abbott Laboratories
- BASF SE
- BeyondSpring Inc.
- BioMarin Pharmaceutical Inc.
- Bristol Myers Squibb Co.
- Croda International Plc
- DEKRA SE
- EID Parry India Ltd.
- Eisai Co. Ltd.
- GFR Pharma
- GlaxoSmithKline Plc
- Jazz Pharmaceuticals Plc
- Koninklijke DSM NV
- MARINE LIFESCIENCES
- Merck KGaA
- Pfizer Inc.
- PharmaMar SA
- Roquette Freres SA
- TerSera Therapeutics LLC
- ZELNOVA ZELTIA S.A.
Also, the marine pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
For more information about this report visit https://www.researchandmarkets.com/r/2cboqd
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
